NCT00285259 Cytomegalovirus (CMV) Vaccine in Donors and Recipients Undergoing Allogeneic Hematopoietic Cell Transplant (HCT) Status COMPLETED Phase PHASE2
NCT00276159 Study of Immune Response Modifier in the Treatment of Hematologic Malignancies Status TERMINATED Phase PHASE2
NCT00270881 Safety and Efficacy of Unrelated Cord Blood Transplantation for Adult Patients With Hematologic Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT00222612 Medical Research Council (MRC) Working Party on Leukaemia in Children UK National Acute Lymphoblastic Leukaemia (ALL) Trial: UKALL 2003 Status UNKNOWN Phase PHASE4
NCT00222027 Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial Status COMPLETED Phase PHASE2
NCT00192673 Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses Status UNKNOWN Phase PHASE4
NCT00187005 Total Therapy Study XIV for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE3
NCT00186875 Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00184041 Intensified Post Remission Therapy Containing PEG-Asparaginase Status COMPLETED Phase PHASE2
NCT00171249 An Extension Study to Determine the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Participants With Ph+ Leukemia Status COMPLETED Phase PHASE2
NCT00144963 Liposomal Vincristine Plus Dexamethasone in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT00144703 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00144677 Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation Status COMPLETED Phase PHASE2
NCT00143559 Stem Cell Transplantation as Immunotherapy for Hematologic Malignancies Status COMPLETED Phase PHASE2
NCT00136435 A Study in Adults With Untreated Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00130195 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT00103285 Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3